Quick answer
Tesamorelin is verified by reversed-phase HPLC for purity and mass spectrometry for identity, with the N-terminal hexenoyl cap as the key check.
- Identity: average mass about 5136 Da; without the cap, about 5040 Da
- Challenge: a 44-residue chain, so deletion sequences are the main impurities
- Oxidation: Met27 sulfoxide, +16 Da
- Product: Tesamorelin, 10 mg lyophilized, formula C221H366N72O67S
- Concentration: mg ÷ mL; see the calculator
For laboratory research use only; not for human consumption.
What tesamorelin is, analytically
Tesamorelin's research value depends on both its GHRH-fragment backbone and its distinctive N-terminal modification being correctly synthesized, which makes lot-level analytical testing especially informative. The peptide portion is the complete 44-residue GHRH sequence with an amidated C-terminus, and the modification is a trans-3-hexenoyl group attached to the N-terminal tyrosine. At more than 5 kDa it is among the larger synthetic peptides in routine research supply. The V8 tesamorelin product page lists the molecular formula C221H366N72O67S and the N-terminal trans-3-hexenoyl-Tyr sequence; the receptor and design background is in the tesamorelin research overview.
Two facts make this molecule harder to certify than a short peptide. First, length: a 44-residue chain needs a long series of coupling cycles, and each imperfect cycle leaves a closely related impurity. Second, the modification: the hexenoyl cap is added as a separate chemical step, so a lot can contain a mixture of capped and uncapped chains. The tests below target those two risks directly.
| Property | Value | Why it matters analytically |
|---|---|---|
| Backbone | GHRH(1-44), C-terminal amide | Long chain, so deletion sequences accumulate |
| N-terminal modification | trans-3-hexenoyl on Tyr1 | Mass shift of about 96 Da confirms presence |
| Approximate average mass | About 5136 Da | Reference value for the deconvoluted spectrum |
| Unacylated GHRH(1-44) amide | About 5040 Da | Result expected if the cap is missing |
| Sermorelin, GHRH(1-29) | About 3358 Da | Easily separated by mass |
| Oxidation-prone residue | Met27 | +16 Da species |
Reversed-phase HPLC
HPLC resolves the fully modified peptide from unmodified fragment and other synthesis byproducts, with the purity figure interpreted per understanding HPLC purity.
A 44-residue synthesis involves many coupling cycles, so deletion sequences are the principal byproducts, and they become harder to separate as chain length increases. Wide-pore columns and long, shallow gradients are commonly used. The methionine at position 27 can oxidize and asparagine residues can deamidate during storage, each giving a closely eluting variant.
The hexenoyl group is hydrophobic, so the capped peptide is retained longer than the uncapped one and the two usually separate cleanly. That makes HPLC a useful first look at capping efficiency; mass spectrometry then confirms which peak is which.
| Impurity | Mass relative to parent | Chromatographic behavior |
|---|---|---|
| Uncapped GHRH(1-44) amide | About −96 Da | Earlier than the main peak |
| Met27 sulfoxide | +16 Da | Earlier, close to main peak |
| Deamidated variant (Asn to Asp or isoAsp) | +1 Da | Very close; best seen chromatographically |
| Deletion sequences | Minus one residue mass | Close to main peak; need shallow gradient |
| Truncated chains from failed couplings | Much lower mass | Usually well separated |
Mass spectrometry for identity
The added trans-3-hexenoic acid group described in the chemistry article shifts the molecule's mass in a way mass spectrometry can directly confirm, distinguishing correctly modified tesamorelin from unmodified GHRH-fragment analogs such as sermorelin; see HPLC vs. mass spectrometry.
The theoretical average mass of tesamorelin is about 5136 Da, roughly 96 Da above unacylated GHRH(1-44) amide, and far from sermorelin at about 3358 Da. Electrospray produces a ladder of multiply charged ions that is deconvoluted to the intact mass. Oxidation adds 16 Da; deamidation adds only 1 Da and is usually detected chromatographically.
A basic peptide of this size typically gives many charge states, often from about 5+ to 10+ or higher, so the raw spectrum is a series of peaks that the instrument software converts into one neutral mass. On a report, look for the deconvoluted value and the theoretical value printed together. Agreement within a fraction of a dalton on a high-resolution instrument, or within a few daltons on a lower-resolution one, is the identity statement.
Why the modification matters analytically
Because tesamorelin's enzymatic-degradation resistance is the entire basis of its research utility (detailed in its mechanism of action), a lot lacking the full modification would not behave as expected in a stability-dependent protocol even if it appeared superficially similar.
The hexenoyl group blocks the N-terminus against dipeptidyl peptidase-4, the enzyme that removes the first two residues of unmodified GHRH. Stability comparisons in serum-containing media are therefore a direct functional consequence of what the mass spectrum confirms. The sibling comparison with the shorter native-sequence fragment is laid out in the tesamorelin vs. sermorelin comparison.
The practical consequence is simple: a lab designing a protease-stability experiment should regard the 5136 Da versus 5040 Da distinction as a go/no-go criterion for the lot, and should not rely on a purity percentage alone to settle it.
Reading the tesamorelin chromatogram
HPLC purity for tesamorelin is reported as area percent: the main peak's share of all UV-absorbing material detected, normally at 214–220 nm. Three things make that number trustworthy. First, the method must be stated, including column chemistry, mobile phases, and gradient slope, because resolution determines what counts as a separate impurity. Second, the trace should show a clean baseline and a main peak free of fronting, tailing, or shoulders that hint at co-eluting species. Third, the integration table should account for every minor peak, so the percentage reflects the whole sample and not a selectively drawn window.
For a molecule this large, peak width also matters. Broad peaks lose resolving power, and a poorly shaped main peak can conceal deletion sequences underneath it. Wide-pore stationary phases and elevated column temperatures are used to sharpen large-peptide peaks; a method that discloses them is easier to trust.
What an HPLC percentage leaves out
Two quantities are easy to confuse: purity and content. Purity is the proportion of UV-absorbing peptide that is the target molecule. Content is the proportion of the dry powder that is peptide at all, once counter-ions and residual water are subtracted. A lot can be very pure and still carry a meaningful salt and moisture fraction, which matters when preparing standards by mass. The peptide calculator is a convenient way to plan reconstitution volumes and resulting concentrations.
For scale, a 10 mg vial brought up in 2 mL gives a nominal 5 mg/mL stock, which at a molecular weight near 5136 g/mol is about 0.97 mM. If net peptide content were 85% of gross mass, the true concentration would be about 4.25 mg/mL. The ratio is the same in any units; the point is that gross label mass and net peptide mass differ. Further background on concentration math is in the tesamorelin reconstitution and storage article.
| Labeled mass | Diluent volume | Nominal concentration | Approx. molarity (MW about 5136) |
|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | About 1.9 mM |
| 10 mg | 2 mL | 5 mg/mL | About 0.97 mM |
| 10 mg | 5 mL | 2 mg/mL | About 0.39 mM |
Documentation to expect
A lot-specific certificate of analysis with HPLC purity and mass-spec identity is the baseline; see how to read a CoA and third-party testing explained. A useful tesamorelin certificate is specific and traceable. It should show:
- The lot number, linking the document to a physical vial
- Chromatographic purity with the underlying trace and method
- Mass-spectrometric identity, with theoretical and measured values side by side
- Who ran the tests and when
Lot-level documents are available from the CoA library. The tesamorelin product page lists the 10 mg vial as lyophilized powder with HPLC purity of at least 98% and links to a published lot certificate; the lot number it shows should be matched against the vial received.
Keeping a verified lot verified
Verified purity is not permanent. Tesamorelin stored as dry powder in cold, dark conditions holds its profile far longer than material kept in solution, where hydrolysis, oxidation, and adsorption to container surfaces proceed more quickly. Recording reconstitution dates, minimizing freeze-thaw cycles, and keeping a retained aliquot for re-analysis gives a lab a way to rule material degradation in or out when a result looks anomalous. The product page lists storage at 2–8 °C, with −20 °C for long-term storage, away from heat, moisture and light; broader practice is in storing research peptides.
Large peptides also adsorb to glass and plastic surfaces at low concentration, so losses in dilute working solutions can be mistaken for degradation. Comparing a freshly prepared solution against an aged one by the same HPLC method separates the two explanations.
Tesamorelin FAQ
What mass should a tesamorelin certificate show?
A deconvoluted value consistent with about 5136 Da. A result near 5040 Da would suggest the N-terminal hexenoyl group is absent.
Why are long peptides harder to purify?
Each additional coupling step can generate a deletion product that differs from the target by a single residue. In a 44-residue chain those byproducts are proportionally very similar to the full-length peptide and need high-resolution chromatography to remove.
How does mass spectrometry tell tesamorelin from sermorelin?
Sermorelin is GHRH(1-29) at about 3358 Da, while tesamorelin is the 44-residue peptide plus a hexenoyl group at about 5136 Da. The difference is nearly 1800 Da.
What does a +16 Da peak mean?
Oxidation, most often of methionine 27 to the sulfoxide. It is a storage-related change and appears as a closely eluting, slightly earlier peak on HPLC.
Can HPLC alone confirm the hexenoyl cap?
It can suggest it, because the capped form is more retained than the uncapped one, but only mass data identify which peak is which.
Why is a deamidation product hard to see by mass?
Deamidation changes mass by only about 1 Da, which is within the isotope envelope of a 5 kDa peptide. It is usually detected as a separate chromatographic peak.
What is the difference between purity and net peptide content?
Purity is the target peptide's share of UV-absorbing material; content is the peptide's share of the whole powder. Counter-ions and water lower content without affecting purity.
Where are tesamorelin background questions answered?
The tesamorelin research overview covers structure, stability, comparisons with other GHRH analogs, and handling. See also the tesamorelin product page.
Research Use Only. For laboratory research use only; not for human consumption. This article is research education, not usage guidance.